Citace podle APA

Gross, M. E., Dorff, T. B., Quinn, D. I., Diaz, P. M., Castellanos, O. O., & Agus, D. B. (2017). Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC). Clin Genitourin Cancer.

Styl Chicago

Gross, Mitchell E., Tanya B. Dorff, David I. Quinn, Patricia M. Diaz, Olga O. Castellanos, a David B. Agus. "Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)." Clin Genitourin Cancer 2017.

Citace podle MLA

Gross, Mitchell E., et al. "Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)." Clin Genitourin Cancer 2017.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..